Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daprodustat versus recombinant human erythropoietin in dialysis patients with chronic kidney disease anemia
2016-000541-31Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of daprodustat in anemia of renal disease (2 arms), sponsored by GSK. Started Oct 2016; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on 2016-000541-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000541-31.